Evidence map›Paper›PMID 38086920›Full record

ArticleNature communications2023

A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization.

Brett Volmert, Artem Kiselev, Aniwat Juhong, Fei Wang, Ashlin Riggs, Aleksandra Kostina, Colin O'Hern, Priyadharshni Muniyandi, Aaron Wasserman, Amanda Huang and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Human cardiovascular organoids: Biomedical applications and ethical challenges.American heart journal plus : cardiology research and practice · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Brett VolmertInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.ORCID 0000-0002-5209-4833
Artem KiselevInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Aniwat JuhongInstitute for Quantitative Health Science and Engineering, Division of Biomedical Devices, Michigan State University, East Lansing, MI, USA.
Fei WangDepartment of Biomedical Engineering, Washington University in Saint Louis, Saint Louis, MO, USA.ORCID 0000-0002-0890-4595
Ashlin RiggsInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Aleksandra KostinaInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Colin O'HernInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.ORCID 0000-0002-5896-2101
Priyadharshni MuniyandiInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Aaron WassermanInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Amanda HuangInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Yonatan Lewis-IsraeliInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.ORCID 0000-0001-9993-0707
Vishal PandaDepartment of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Sudin BhattacharyaDepartment of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.ORCID 0000-0002-2360-1672
Adam LauverDepartment of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Sangbum ParkInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA.
Zhen QiuInstitute for Quantitative Health Science and Engineering, Division of Biomedical Devices, Michigan State University, East Lansing, MI, USA.ORCID 0000-0001-8790-8481
Chao ZhouDepartment of Biomedical Engineering, Washington University in Saint Louis, Saint Louis, MO, USA.ORCID 0000-0002-8679-3413
Aitor AguirreInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, East Lansing, MI, USA. aaguirre@msu.edu.ORCID 0000-0002-1383-2792
Michigan State University · USQuantitative BioSciences · USWashington University in St. Louis · US

Funding

Oxylipin Signaling in Congenital Heart DiseaseR01HL151505 · NHLBI · MICHIGAN STATE UNIVERSITY · PI AGUIRRE, AITOR · 2021 to 2025
$2.2M
High-throughput integrated live imaging and optogenetic pacing platform to assess hypoxia responsiveness in the fly heartR01HL156265 · NHLBI · WASHINGTON UNIVERSITY · PI ZHOU, CHAO · 2021 to 2024
$2.1M
High throughput optical coherence tomography (OCT)-based imaging platform for label-free, non-invasive characterization of 3D tumor spheroids.R01EB025209 · NIBIB · WASHINGTON UNIVERSITY · PI ZHOU, CHAO · 2017 to 2021
$1.4M
Lipid signaling in cardiac development and diseaseK01HL135464 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AGUIRRE, AITOR · 2017 to 2021
$795k
NHLBI NIH HHS K01 HL135464NHLBI NIH HHS R01 HL151505NHLBI NIH HHS R01 HL156265NIBIB NIH HHS R01 EB025209
6 · The paper itself

Abstract

Pluripotent stem cell-derived organoids can recapitulate significant features of organ development in vitro. We hypothesized that creating human heart organoids by mimicking aspects of in utero gestation (e.g., addition of metabolic and hormonal factors) would lead to higher physiological and anatomical relevance. We find that heart organoids produced using this self-organization-driven developmental induction strategy are remarkably similar transcriptionally and morphologically to age-matched human embryonic hearts. We also show that they recapitulate several aspects of cardiac development, including large atrial and ventricular chambers, proepicardial organ formation, and retinoic acid-mediated anterior-posterior patterning, mimicking the developmental processes found in the post-heart tube stage primitive heart. Moreover, we provide proof-of-concept demonstration of the value of this system for disease modeling by exploring the effects of ondansetron, a drug administered to pregnant women and associated with congenital heart defects. These findings constitute a significant technical advance for synthetic heart development and provide a powerful tool for cardiac disease modeling.

Indexed as

Heart DiseasesInduced Pluripotent Stem CellsPluripotent Stem CellsCell DifferentiationFemaleHeartHumansOrganoidsPregnancy

Identifiers

PMID38086920
PMCPMC10716495
OpenAlexW4389613261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.